Your session is about to expire
← Back to Search
CACTUX for Head and Neck Cancer (CACTUX Trial)
CACTUX Trial Summary
This trial is testing a new cancer treatment called CACTUX. It's a combination of 3 drugs, and the investigators want to see if it's effective and has fewer side effects than the standard treatment.
CACTUX Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCACTUX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CACTUX Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had cancer other than my current one in the last 2 years, with some exceptions.I have cancer that has spread to my brain.I am HIV positive and on antiretroviral therapy.My blood, kidney, and liver functions are all within normal ranges.I have received treatment for a disease considered incurable.I am fully active and can carry on all pre-disease activities without restriction.It has been over 4 months since I finished my treatment aimed at curing my disease.My cancer in the head or neck area is confirmed and cannot be cured.I do not have any uncontrolled illnesses.I have moderate to severe numbness, tingling, or pain in my hands or feet.I am 18 years old or older.
- Group 1: CACTUX: nab-paclitaxel, cisplatin (or carboplatin), cetuximab
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Cetuximab been the subject of any prior research studies?
"Cetuximab's inception dates back to 1997 when City of Hope Comprehensive Cancer Center launched its first trial. Since then, there have been 2676 trials completed, with 1688 currently in progress - the majority of which are taking place at Saint Louis Medical Centre."
What principal conditions does Cetuximab aim to ameliorate?
"Cetuximab is able to manage the symptoms of neoplasm metastasis, APN, and non-Hodgkin's lymphoma."
Is this research project accepting new participants at present?
"This particular clinical trial has concluded its recruitment, with the first posting on February 2nd 2015 and the most recent edit occuring August 3rd 2022. If seeking out other trials, 3008 studies for head neoplasms are presently open to patients while 1688 acceptances are available within Cetuximab-related research."
What kind of adverse effects have been associated with Cetuximab?
"Taking into account the current clinical information available, Cetuximab is rated as a 2 in terms of safety. This rating reflects that although there is some evidence supporting its security profile, no data exists to validate efficacy."
To what extent has the participant pool expanded for this research project?
"Currently, this medical trial is not accepting patients. It was initially posted on February 2nd 2015 and last updated on August 3rd 2022. For those seeking alternative clinical trials, there are 3,008 studies recruiting head neoplasms sufferers and 1,688 trials involving Cetuximab that are actively searching for volunteers."
How many facilities are managing this research endeavor?
"Several medical centres are currently looking for participants in this trial, including Washington University School of Medicine in Saint Louis, the University of Mississippi Medical Center in Jackson, and Sanford Roger Maris Cancer Center in Fargo. Additionally, there are two other locations actively recruiting patients."
Share this study with friends
Copy Link
Messenger